Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Gynecologic Cancers
•
Cervical Cancer
In a patient with prior LEEP and no residual cervix found to have HSIL on ECC, what type of hysterectomy would you offer?
Related Questions
Given the results of KEYNOTE-A18, do you plan to recommend adding pembrolizumab to primary chemoradiotherapy for advanced stage cervical cancer?
What factors, if any, besides Sedlis Criteria do you consider when deciding on adjuvant RT in cervical cancer patients?
What is your approach to lymph node evaluation in patients undergoing radical hysterectomy for early cervical cancer?
What brachytherapy regimen would you use for a patient who completed only the EBRT portion of their planned definitive chemoradiation course for locally advanced cervical cancer, who is now presenting with persistent/recurrent local disease?
In light of the SHAPE trial results, how would you manage a patient with an incidentally diagnosed FIGO IA1 cervical cancer after simple extrafascial hysterectomy/BSO?
In a patient with previous cervix cancer treated with surgery and adjuvant EBRT who presents with recurrent HGSIL, status post vaginectomy, would you consider brachytherapy?
Do you have a BMI cutoff for abdominal radical hysterectomy for cervical cancer?
Do you recommend progesterone for endometrial protection in a young woman on estrogen replacement therapy for iatrogenic menopause after definitive radiation therapy for locally advanced cervical cancer?
How do you think the BEATcc trial will change management of patients with advanced or recurrent cervical cancer?
What are your top takeaways in Gynecologic Cancers from ASCO 2023?
